Hypnotherapy Session Note (Menopausal Vasomotor Symptoms)

Patient: [Full name] | DOB: [DOB] | MRN: [MRN]
Date/Time: [Encounter date]; [Start–Stop time or total face-to-face minutes]
Session: [# of # in current episode]
Modality: [in-person / telehealth]
Provider: [Name, credentials]

Reason for Visit

[Patient-stated concern or agreed treatment focus] (Use patient wording if it clarifies burden. Limit to 1–2 lines.)

Subjective

Interval symptom status: [Measurement window: past 7 days / 3-day diary / other]

• Hot flashes: [Count per day] [diary / patient estimate]
• Night sweats: [Count per night] [diary / patient estimate]
• Average severity: [Rating on specified scale]
• Sleep disruption: [Awakenings, re-entry latency, total sleep impact]
• Trend vs. baseline/last session: [improved / stable / worsened] [Brief numeric comparison]
• Context: [Relevant stressors, triggers, medication changes, illness]

Home practice adherence: [Self-hypnosis frequency and duration], [Recording use], [Application during prodrome or awakenings], [Barriers or adverse responses] (Briefly interpret whether adherence is adequate to expect benefit.)

Narrative context: [Sleep quality, stress/anxiety, appraisal of symptoms, session goals] (Limit to 2–4 sentences; omit if visit is purely skills-focused.)

(If diary not completed, document reason, label estimates as such, and note plan to restore tracking. For first visit, note "baseline pending" with plan to obtain.)

Objective

General observations: [Appearance, engagement, distress level]

Mental status: [Safety-relevant observations only: affect, orientation, risk concerns if any]

Standardized measures: [Instrument, score, date] (Include only if collected this visit.)

Telehealth quality: [Audio/video issues impacting care] (Omit if not applicable.)

Assessment

• Vasomotor symptoms: [Current severity], [Trend vs. baseline/last session with supporting numbers], [Key contributing factors]
• Sleep disruption: [Status and drivers: night sweats vs. conditioned arousal] (Include only if clinically relevant.)
• Self-hypnosis adherence/self-efficacy: [Skill acquisition level], [Barriers], [Readiness to progress]
• Comorbid mood/anxiety: [Brief relevant impact] (Include only if materially affecting VMS perception or participation.)
• Medical concerns: [Concern and recommended follow-up] (Include only if new concern arises; do not diagnose outside scope.)

Intervention

Approach: [Induction method], [Therapeutic targets], [Imagery theme], [Suggestion categories delivered], [Self-hypnosis training elements: cue word, breathing anchor], [Audio recording: provided / reviewed / not used]

Response: [Patient-reported depth/engagement], [Observed physiologic relaxation cues], [In-session symptom change if reported], [Adverse effects: none / describe]

(If detailed scripts or sensitive disclosures require documentation, note that process notes are maintained separately per HIPAA psychotherapy note provisions.)

Plan

• Home practice: [Frequency], [Duration], [Timing: bedtime / awakenings / prodrome / scheduled], [Recording instructions] (Specify exact actions; avoid vague terms.)
• Tracking: [Diary method and metrics], [Duration], [When to complete before next session]
• Next session focus: [Planned imagery/suggestion adjustments], [Barrier troubleshooting], [Additional strategies]
• Care coordination: [Communication with menopause clinician or other providers], [ROI status] (Omit if not applicable.)
• Follow-up: [Next appointment date/time or recommended interval]

Signature: [Provider name, credentials] | [Date/time signed]

(Include telehealth or supervision attestation only if required by setting.)